Sun Pharma receives EIR for Halol facility
Warning letter issued in December 2015 have been addressed
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
AstraZeneca, Eli Lilly scrap Alzheimer’s treatment trial
The two firms had announced a partnership to develop a new drug aimed at combatting Alzheimer's in 2014
Suven Life Sciences gets product patents from China, US
Patents are being developed as therapeutic agents useful in treatment of cognitive impairment associated with neurodegenerative…
CPhI & P-MEC India 2018 move to Indian capital
The India Expo Mart brings the event closer to Indian regulatory and legislative hub and will encourage international audiences
Oviya MedSafe to organise IndUS Drug Safety – one day workshop in Mumbai
The workshop will be open to pharma companies, with preference to representatives from Pharmacovigilance / Regulatory Affairs /…
The case of Apotex vs Cadila
In a case of Apotex vs Cadila, the former shares details of how the court refused to grant anti-suit injunction to Cadila and…
Alembic Pharma gets USFDA approval for Bupropion Hydrochloride tablets
The drug approval is for strengths of 75 mg and 100 mg and is used to treat major depressive disorder
OPPI’s summit discusses on importance of quality standards for pharma industry
Pharma companies, government bodies, patient activists and healthcare practitioners gather to discuss how quality can become a key…
Cipla, Unitaid ink pact to cut price of HIV drug Geneva
The combination therapy is a once-daily pill that protects in three ways against TB
Cipla partners with Eli Lilly & Company to market diabetes drug BASAGLAR
BASAGLAR is a once-daily insulin glargine therapy for the treatment of patients with type 1 & 2 diabetes above two years of…